Medtronic plc.

Open: 85.7 Close: 85.89 Change: 0.19

Try an AI to get informed about investing in Medtronic plc..

The game is changing. There is a new strategy to evaluate Medtronic plc. fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, Medtronics, stock, price, PLC, MDT, new, …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Medtronic PLC stock falls Friday, still outperforms market - marketwatch.com. The Score for MDT is 53, which is 6% above its historic median score of 50. Morgan Stanley raised shares of the company from an “equal weight” rating to an ‘overweight’ rating.

Today's News

Medtronic PLC stock falls Friday, still outperforms market - marketwatch.com. Shares of Medtronics PLC shed 0.21% to $85.89. Medtronic PLC (MDT) stock is a good choice for value-oriented investors right now. The stock price of MDT is 85.89 and 200-day moving average is 82.95, creating a Buy signal. Medtronic PLC stock price is 85.89 USD today. The Score for MDT is 53, which is 6% above its historic median score of 50. Medtronic board appoints Greg Lewis, Senior Vice President and Chief Financial Officer at Honeywell, to become new Director. The employee data is based on information from people who have self-reported their past or current employments at Medtronic. None of the information on this page has been provided or approved by Medtronics. The data does not represent the view of Medtron and its employees. CL King assumed coverage on shares of Medtronic in a research report on Friday, June 30th. Morgan Stanley raised shares of the company from an “equal weight” rating to an ‘overweight’ rating. 92 Resources reaffirmed a “maintains” status on shares. Medtronic is approaching the half-century mark for dividend growth. Virtua Health is now using Medtronics GI Genius endoscopy module at five of its hospitals. Medtronic PLCs solvency score is59/100. The higher the solveny score, the more solvent the company is. The last transaction was made onJan 30, 2023by Medtronics Plc (10 percent owner), whobought63.4k USD. Institutional investors own approximately 80.48% of Medtronic stock on the NYSE under ticker symbol MDT as of Mondays opening price of $88.10 per share. Morgan Stanley upgraded Medtronics rating from “equal weight” to “overweight” Morgan Stanley set a new price target of $104. CB Insights Intelligence Analysts have mentioned Medtronic in 6 CB Insight research briefs. Medtronics recently partnered with Allurion on June 6, 2023. The average price target for the company is $2.76. Rosen Law Firm reminds purchasers of Medtronic stock between June 8, 2019 and May 25, 2022, of the important November 7, 2022 lead plaintiff deadline. If you purchased Medtronics securities during the Class Period you may be entitled. Medtronic was founded in 1949 and is headquartered in Dublin, Ireland. The company said in a news release that the new guidelines follow a series of favorable position papers and consensus statements from ESH. The trend to design capable medical devices for home and mobile care is not new.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

This document will help you to evaluate Medtronic plc. without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, Medtronics, stock, price, PLC, MDT, new, and the most common words in the summary are: medtronic, stock, market, plc, mdt, job, price, . One of the sentences in the summary was: The Score for MDT is 53, which is 6% above its historic median score of 50. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #market #plc #mdt #job #price.